SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
IDG-Accel China Growth Fund III L.P.

(Last) (First) (Middle)
UNIT 5505, THE CENTRE
99 QUEEN'S ROAD, CENTRAL

(Street)
K3

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CASI Pharmaceuticals, Inc. [ CASI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director X 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
03/07/2013
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/07/2013 P 972,708 A $2.4(3) 5,091,438 D(1)
Common Stock 03/07/2013 P 68,958 A $2.4(3) 360,947 I(2) See Explanation of Responses(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrant $2.91 03/07/2013 P 486,354 09/04/2013 09/04/2016 Common Stock 486,354 $0(3) 1,298,354 D(1)
Warrant $2.91 03/07/2013 P 34,479 09/04/2013 09/04/2016 Common Stock 34,479 $0(3) 92,044 I(2) See Explanation of Responses(2)
1. Name and Address of Reporting Person*
IDG-Accel China Growth Fund III L.P.

(Last) (First) (Middle)
UNIT 5505, THE CENTRE
99 QUEEN'S ROAD, CENTRAL

(Street)
K3

(City) (State) (Zip)
1. Name and Address of Reporting Person*
IDG-Accel China III Investors L.P.

(Last) (First) (Middle)
UNIT 5505, THE CENTRE
99 QUEEN'S ROAD, CENTRAL

(Street)
K3

(City) (State) (Zip)
1. Name and Address of Reporting Person*
IDG-Accel China Growth Fund III Associates L.P.

(Last) (First) (Middle)
UNIT 5505, THE CENTRE
99 QUEEN'S ROAD, CENTRAL

(Street)
K3

(City) (State) (Zip)
1. Name and Address of Reporting Person*
IDG-Accel China Growth Fund GP III Associates Ltd.

(Last) (First) (Middle)
UNIT 5505, THE CENTRE
99 QUEEN'S ROAD, CENTRAL

(Street)
K3

(City) (State) (Zip)
1. Name and Address of Reporting Person*
Ho Chi Sing

(Last) (First) (Middle)
UNIT 5505, THE CENTRE
99 QUEEN'S ROAD, CENTRAL

(Street)
K3

(City) (State) (Zip)
1. Name and Address of Reporting Person*
Zhou Quan

(Last) (First) (Middle)
UNIT 5505, THE CENTRE
99 QUEEN'S ROAD, CENTRAL

(Street)
K3

(City) (State) (Zip)
Explanation of Responses:
1. These securities are directly owned by IDG-Accel China Growth Fund III L.P. ("IDG-Accel Growth") and may be deemed to be indirectly beneficially owned by the other reporting persons. IDG-Accel China Growth Fund III Associates L.P. ("IDG-Accel Associates") is the general partner of IDG-Accel Growth. IDG-Accel China Growth Fund GP III Associates Ltd. ("IDG-Accel GP") is the general partner of both IDG-Accel Associates and IDG-Accel China III Investors L.P. ("IDG-Accel Investors"). Chi Sing Ho and Quan Zhou are shareholders and directors of IDG-Accel GP. Pursuant to a securities purchase agreement dated as of March 1, 2013 by and among the Issuer and certain investors (the "Purchase Agreement"), IDG-Accel Growth purchased 972,708 shares of common stock and warrants to purchase 486,354 shares of common stock of the Issuer.
2. These securities are directly owned by IDG-Accel Investors and may be deemed to be indirectly beneficially owned by the other reporting persons. Pursuant to the Purchase Agreement, IDG-Accel Investors purchased 68,958 shares of common stock and warrants to purchase 34,479 shares of common stock of the Issuer.
3. The shares of common stock and the warrants were issued in units consisting of one share of common stock and a warrant to purchase 0.5 shares of common stock. The purchase price was $2.40 per unit. The filing of this statement by the reporting persons shall not be deemed an admission that such persons are, for purposes of Section 16 of the Securities and Exchange Act of 1934 or otherwise, the beneficial owner of any equity securities covered by this statement.
/s/ Chi Sing Ho, Director of IDG-Accel China Growth Fund GP III Associates Ltd., the ultimate general partner of IDG-Accel China Growth Fund III L.P., on behalf of IDG-Accel China Growth Fund III L.P. 01/27/2016
/s/ Chi Sing Ho, Director of IDG-Accel China Growth Fund GP III Associates Ltd., the general partner of IDG-Accel China III Investors L.P., on behalf of IDG-Accel China III Investors L.P. 01/27/2016
/s/ Chi Sing Ho, Director of IDG-Accel China Growth Fund GP III Associates Ltd., the general partner of IDG-Accel China Growth Fund III Associates L.P., on behalf of IDG-Accel China Growth Fund III Associates L.P. 01/27/2016
/s/ Chi Sing Ho, Director, on behalf of IDG-Accel China Growth Fund GP III Associates Ltd. 01/27/2016
/s/ Quan Zhou 01/27/2016
/s/ Chi Sing Ho 01/27/2016
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.